HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Hypoxia signature of splice forms of tryptophanyl-tRNA synthetase marks pancreatic cancer cells with distinct metastatic abilities.

AbstractOBJECTIVES:
Pancreatic cancer is one of most deadly because of its aggressive growth and high metastatic ability that correlates with intratumoral hypoxia. Earlier diagnosis and prognosis marker of pancreatic cancer is not yet available. In colorectal cancer, protein biosynthesis enzyme, tryptophanyl-tRNA synthetase (TrpRS), is up-regulated in good-prognosis tumors and down-regulated in metastatic poor-prognosis tumors. Tryptophanyl-tRNA synthetase status in pancreatic cancer is unknown. To correlate metastatic ability with hypoxia and TrpRS as a possible prognostic marker, we examined mRNA and protein expression in 2 human pancreatic cancer cell lines with different metastatic abilities and TrpRS levels using our site-specific monoclonal antibodies directed to conformation-dependent epitopes on pancreatic TrpRS.
METHODS:
Pancreatic MIAPaCa-2, Panc-1, cervical HeLa, and prostate cancer PC-3 cells were cultivated under normoxia or in hypoxic chamber. Expression of full-length TrpRS, antiangiogenic TrpRS, cyclin B1, hypoxia-inducible factor 1α, and Glut-1 was determined with reverse transcriptase-polymerase chain reaction, immunoblotting, and immunocytochemistry.
RESULTS:
We demonstrate that hypoxia regulates differentially TrpRS splice forms. Pronounced down-regulation of full-length TrpRS by hypoxia is concomitant with higher metastatic ability.
CONCLUSIONS:
Tryptophanyl-tRNA synthetase down-regulation by hypoxia may be a factor responsible for low TrpRS in tumors with high metastatic ability. Tryptophanyl-tRNA synthetase recognizability is important for pancreatic cancer prognosis and as a new target for metastasis treatment.
AuthorsElena L Paley, Deana E Paley, Tatyana Merkulova-Rainon, Pochi R Subbarayan
JournalPancreas (Pancreas) Vol. 40 Issue 7 Pg. 1043-56 (Oct 2011) ISSN: 1536-4828 [Electronic] United States
PMID21926542 (Publication Type: Journal Article)
Chemical References
  • Biomarkers, Tumor
  • CCNB1 protein, human
  • Cyclin B1
  • Glucose Transporter Type 1
  • HIF1A protein, human
  • Hypoxia-Inducible Factor 1, alpha Subunit
  • Protein Isoforms
  • RNA, Messenger
  • SLC2A1 protein, human
  • Tryptophan-tRNA Ligase
  • WARS1 protein, human
  • Oxygen
Topics
  • Biomarkers, Tumor (genetics, metabolism)
  • Blotting, Western
  • Cell Hypoxia
  • Cyclin B1 (metabolism)
  • Down-Regulation
  • Gene Expression Regulation, Enzymologic
  • Gene Expression Regulation, Neoplastic
  • Glucose Transporter Type 1 (metabolism)
  • HeLa Cells
  • Humans
  • Hypoxia-Inducible Factor 1, alpha Subunit (metabolism)
  • Immunohistochemistry
  • Neoplasm Invasiveness
  • Oxygen (metabolism)
  • Pancreatic Neoplasms (enzymology, genetics, pathology)
  • Protein Isoforms
  • RNA, Messenger (metabolism)
  • Reverse Transcriptase Polymerase Chain Reaction
  • Spheroids, Cellular
  • Time Factors
  • Tryptophan-tRNA Ligase (genetics, metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: